JAMA oncology

ISSN: 2374-2437

Journal Home

Journal Guideline

JAMA oncology Q1 Unclaimed

American Medical Association United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

JAMA oncology is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 173. It has a price of 4598 €. It has an SJR impact factor of 7,843 and it has a best quartile of Q1. It has an SJR impact factor of 7,843.

JAMA oncology focuses its scope in these topics and keywords: cancer, breast, response, outcomes, paclitaxel, recurrence, pathologic, complete, testing, digital, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: weekly

WOS
Categories: Cancer Research (Q1) Oncology (Q1)
Price

4598 €

Inmediate OA

0 €

Embargoed OA

0 €

Non OA

Metrics

JAMA oncology

7,843

SJR Impact factor

173

H Index

349

Total Docs (Last Year)

1225

Total Docs (3 years)

6132

Total Refs

9916

Total Cites (3 years)

523

Citable Docs (3 years)

7.62

Cites/Doc (2 years)

17.57

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, breast, response, outcomes, paclitaxel, recurrence, pathologic, complete, testing, digital, metastatic, colorectal, years, capecitabine, clinical, criteria, candesartan, cancervalidation, careracialethnic, bevacizumab, biomarker, blockadecomplementary, bonetargeted, canceranalysis, cancerglobal, cancerincorrect, cancersuggestibility,

FAQS